Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: Turning Point Prices Ipo, Raising $166M To Test Cancer Drugs
Venture Capital

Xconomy: Turning Point Prices Ipo, Raising $166M To Test Cancer Drugs

by xconomy.com posted 4months ago 16 views
Turning Point Therapeutics raised more than $166 million in its IPO, pricing at the top of its range and putting nearly 2 million more shares into the public markets than it had initially planned. Strong demand ahead of the offering prompted the company, which is developing targeted cancer drugs for patients that have developed resistance […]

In this article